BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Share Price

 

 

Start SIP in BIOFILCHEM

Start SIP

Performance

  • Low
  • ₹30
  • High
  • ₹31
  • 52 Week Low
  • ₹29
  • 52 Week High
  • ₹57
  • Open Price₹30
  • Previous Close₹30
  • Volume9,212
  • 50 DMA₹34.34
  • 100 DMA₹37.19
  • 200 DMA₹41.68

Investment Returns

  • Over 1 Month -10.71%
  • Over 3 Month -23.18%
  • Over 6 Month -35.91%
  • Over 1 Year -44.69%

Smart Investing Starts Here Start SIP with Biofil Chemicals & Pharmaceuticals for Steady Growth!

Invest Now

Biofil Chemicals & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 17
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 49
  • P/B Ratio
  • 2.3
  • Average True Range
  • 1.99
  • EPS
  • 1.76
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.92
  • RSI
  • 32.3
  • MFI
  • 33.46

Biofil Chemicals & Pharmaceuticals Financials

Biofil Chemicals & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹29.93
+ 0.05 (0.17%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹32.24
  • 50 Day
  • ₹34.34
  • 100 Day
  • ₹37.19
  • 200 Day
  • ₹41.68

Resistance and Support

30.19 Pivot Speed
  • R3 31.81
  • R2 31.36
  • R1 30.64
  • S1 29.47
  • S2 29.02
  • S3 28.30

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 42.52 Cr. on a trailing 12-month basis. An annual revenue de-growth of -17% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 2% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 77 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Biofil Chemicals & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-12 Quarterly Results
2025-05-30 Audited Results
2025-02-11 Quarterly Results & Others To consider other business matters.
2024-11-14 Quarterly Results

Biofil Chemicals & Pharmaceuticals F&O

Biofil Chemicals & Pharmaceuticals Shareholding Pattern

46.79%
0%
0.04%
38.27%
14.9%

About Biofil Chemicals & Pharmaceuticals

  • NSE Symbol
  • BIOFILCHEM
  • BSE Symbol
  • 524396
  • Chairman & Managing Director
  • Mr. Ketan Shah
  • ISIN
  • INE829A01014

Similar Stocks to Biofil Chemicals & Pharmaceuticals

Biofil Chemicals & Pharmaceuticals FAQs

Biofil Chemicals & Pharmaceuticals share price is ₹29 As on 26 January, 2026 | 00:42

The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹48.7 Cr As on 26 January, 2026 | 00:42

The P/E ratio of Biofil Chemicals & Pharmaceuticals is 17 As on 26 January, 2026 | 00:42

The PB ratio of Biofil Chemicals & Pharmaceuticals is 2.3 As on 26 January, 2026 | 00:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23